COLL - Collegium Pharmaceutical Inc. (COLL) CEO Joe Ciaffoni on Q1 2021 Results - Earnings Call Transcript

Collegium Pharmaceutical, Inc. (COLL) Q1 2021 Earnings Conference Call May 06, 2021 4:30 PM ET Company Participants Alex Dasalla - Head of Investor Relations Joe Ciaffoni - President & Chief Executive Officer Paul Brannelly - Executive Vice President & Chief Financial Officer Scott Dreyer - Executive Vice President & Chief Commercial Officer Conference Call Participants Tim Lugo - William Blair David Steinberg - Jefferies David Amsellem - Piper Sandler Gregg Gilbert - Truist Securities Serge Belanger - Needham & Company Brandon Folkes - Cantor Fitzgerald Presentation Operator Greetings, and welcome to the Collegium Pharmaceutical First Quarter 2021 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Alex Dasalla. Please go ahead. Alex Dasalla Welcome to Collegium Pharmaceutical's first quarter 2021 earnings conference call. This is Alex Dasalla, Head of Investor Relations for Collegium. I am joined today by

For further details see:

Collegium Pharmaceutical, Inc. (COLL) CEO Joe Ciaffoni on Q1 2021 Results - Earnings Call Transcript